SWAN-GANZ HEMA70CC2Recalls & reported problems
Edwards Lifesciences LLC · Patient CCO cable - HemoSphere Alta advanced monitoring platform · Class 2
All models of SWAN-GANZ (13)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00690103217704), received between Jul 11, 2024 and Dec 12, 2025 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Incorrect, Inadequate or Imprecise Result or Readings” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Incorrect, Inadequate or Imprecise Result or Readings2
Patient problems
- No Clinical Signs, Symptoms or Conditions2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionDec 12, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED THAT, DURING USE, A CCO CABLE HAD LOW BLOOD TEMPERATURE READING AND COULD NOT CALCULATE CO. THE CCO CABLE HAD BLOOD TEMPERATURE OF 89 WHILE THE FOLEY CATHETER HAD 97. CABLE WAS CONNECTED TO AN ALTA MONITOR. THERE WAS NO PATIENT HARM.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23796392 ↗MalfunctionJul 11, 2024Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED THAT THERE WAS A FAILURE WITH THE ALTA MONITOR. THE MONITOR REPORTED 100/100 ON THE ARTERIAL LINE AFTER THE ACUMEN CUFF PRESSURE RELEASE, THIS WAS DURING PATIENT MONITORING. THIS OCCURRED DURING A TARGET MARKETING RELEASE AT A FACILITY. ALL PARAMETERS WERE REPORTING ACCURATELY AT THAT POINT. THE PHYSICIAN ATTEMPTED TO STOP AND RESTART CLEARSIGHT MONITORING. BUT AFTER STOPPING, THE CLINICIAN COULD NOT RESTART DUE TO THE ZEROING REQUIREMENT. THEY ATTEMPTED TO RE-ZERO, BUT COULD NOT DUE TO HEART REFERENCE SENSOR ZEROING STEP. THEY WERE SEEING THE CLEARSIGHT CUFF ZEROING. THERE WAS NO PATIENT HARM OR INJURY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19721530 ↗
Other Computer, Diagnostic, Programmable devices
- ZIO AT Patch A100A100XIrhythm Technologies, Inc. · Computer, Diagnostic, Programmable1 recall14 deaths629 reports
- CARTO 3 FG540000Biosense Webster (Israel) Ltd. · Computer, diagnostic, programmable1 death437 reports
- Sensis 10764561Siemens Healthcare GmbH · COMPUTER, DIAGNOSTIC, PROGRAMMABLE5 recalls8 reports
- Sensis Vibe Hemo 11007641Siemens Healthcare GmbH · COMPUTER, DIAGNOSTIC, PROGRAMMABLE4 recalls1 death22 reports
- Sensis Vibe Combo 11007642Siemens Healthcare GmbH · COMPUTER, DIAGNOSTIC, PROGRAMMABLE4 recalls1 death6 reports
- Change Healthcare Cardiology Hemo 15.1Change Healthcare Canada Company · Computer, Diagnostic, Programmable4 recalls1 report
- Change Healthcare Cardiology Hemo 15.0.1Change Healthcare Canada Company · Computer, Diagnostic, Programmable3 recalls1 death1 report
- Change Healthcare Cardiology Hemo 14.3.2Change Healthcare Canada Company · Computer, Diagnostic, Programmable3 recalls0 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page